$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Oncology
Oncology
Platinib’s scope of application, price, and purchase information
2025-10-19 11:44:20
Check Details
Capmatinib price
2025-10-19 11:44:20
Check Details
Evantumumab first-line treatment of advanced non-small cell lung cancer with EGFR gene exon 20 insertion mutation
2025-10-19 11:44:20
Check Details
Capmatinib’s launch time and indications
2025-10-19 11:44:20
Check Details
Overview of the purchase price and field application of capmatinib
2025-10-19 11:44:20
Check Details
New drug for targeted treatment of gastrointestinal stromal tumors: Ripotinib
2025-10-19 11:44:20
Check Details
Guide to dietary taboos while taking crizotinib
2025-10-19 11:44:20
Check Details
The fourth domestic MET inhibitor: tepotinib hydrochloride was approved for marketing
2025-10-19 11:44:20
Check Details
Entrectinib purchase and analysis of its effects
2025-10-19 11:44:20
Check Details
Detailed explanation of the efficacy and side effects management of ceritinib
2025-10-19 11:44:20
Check Details
The efficacy and safety of Yiluake Tablets (Qixinke) in the treatment of lung cancer
2025-10-19 11:44:20
Check Details
Application of Yiluake Tablets (Qixinke) in the treatment of ALK-positive lung cancer
2025-10-19 11:44:20
Check Details
1
2
...
4131
4132
4133
4134
4135
4136
4137
...
4149
4150
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids
2
How effective is Ryeqo (Relugolix compound tablets)?
3
U.S. FDA approves Ryeqo to treat menorrhagia related to uterine fibroids in premenopausal women!
4
How much does Ryeqo cost? Where can I buy it in Liaoning?
5
Ryeqo - a good medicine that can effectively improve menorrhagia and pain caused by uterine fibroids
6
How much does Ryeqo cost? Is it available in Shandong now?
7
Comprehensive summary-the advantages, disadvantages and indications of different preparations of estradiol
8
What is the therapeutic effect of myfembree
9
What are the serious side effects of myfembree and how to deal with them?
10
How effective is Ryeqo in treating uterine fibroids?
11
How to use Ryeqo correctly?
12
What is the clinical efficacy of Myfembree in treating uterine fibroids?